Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus

Marine Drugs

Volumn 11, Issue 6, 2013, Pages 1836-1852

  Gopal, Ramamourthy ^a   Lee, Jun Ho ^a   Kim, Young Gwon ^a   Kim, Myeong Sun ^a   Seo, Chang Ho ^b   Park, Yoonkyung ^a  

^a Chosun University   (South Korea)

^b Kongju National University   (South Korea)

Author keywords

Antibiofilm peptide; Antimicrobial peptide; Cholesterol; Eukaryotic membrane; Fish peptide; NRC 16; Phosphatidylcholine; Sphingomyelin

Indexed keywords

AMPICILLIN; CEFPIRAMIDE; CHLORAMPHENICOL; CHOLESTEROL; CIPROFLOXACIN; ERYTHROMYCIN; FLOMOXEF; FLUCONAZOLE; GLYCYLTRYPTOPHANYLLYSYLLYSYLTRYPTOPHANYLLEUCYLARGINYLLYSYLGLYCYLALANYLLYSYLHISTIDYLLEUCYLGLYCYLGLUTAMINYLALANYLALANYLISOLEUCYLLYSYLGLYCYLLEUCYLALANYLSERINE AMIDE; ISEPAMICIN; LEVOFLOXACIN; MELITTIN; NATURAL PRODUCT; OXACILLIN; PHOSPHATIDYLCHOLINE; PIPERACILLIN; SPHINGOMYELIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG PENETRATION; DRUG SELECTIVITY; ESCHERICHIA COLI; FLOUNDER; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MACROPHAGE; MEMBRANE MODEL; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TRICHOSPORON BEIGELII; WITCH FLOUNDER;

BACTERIA (MICROORGANISMS); EUKARYOTA; GLYPTOCEPHALUS CYNOGLOSSUS; MAMMALIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84879478218     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11061836     Document Type: Article

References (78)

1. Park, S.C.; Park, Y.; Hahm, K.S. The role of antimicrobial peptides in preventing multidrug resistant bacterial infections and biofilm formation. Int. J. Mol. Sci. 2011, 12, 5971-5992.
2. Dzidic, S.; Suskovic, J.; Kos, B. Antibiotic resistance mechanisms in bacteria: Biochemical and genetic aspects. Food Technol. Biotechnol. 2008, 46, 11-21. (Pubitemid 351767991)
3. Wright, G.D. Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv. Drug Deliv. Rev. 2005, 57, 1451-1470. (Pubitemid 40984601)
4. Lambert, P.A. Bacterial resistance to antibiotics: Modified target sites. Adv. Drug Deliv. Rev. 2005, 57, 1471-1485. (Pubitemid 40984602)
5. Kumar, A.; Schweizer, H.P. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005, 57, 1486-1513. (Pubitemid 40984603)
6. Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284, 1318-1322. (Pubitemid 29289651)
7. Drenkard, E.; Ausubel, F.M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002, 416, 740-743. (Pubitemid 34429150)
8. Ehrlich, G.D.; Veeh, R.; Wang, X.; Costerton, J.W.; Hayes, J.D.; Hu, F.Z.; Daigle, B.J.; Ehrlich, M.D.; Post, J.C. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002, 287, 1710-1715.
9. Singh, P.K.; Schaefer, A.L.; Parsek, M.R.; Moninger, T.O.; Welsh, M.J.; Greenberg, E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407, 762-764.
10. Perron, C.G.; Zasloff, M.; Bell, G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 2006, 273, 251-256. (Pubitemid 46768100)
11. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003, 55, 27-55. (Pubitemid 36268398)
12. Giuliani, A.; Pirri, G.; Nicoletto, S.F. Antimicrobial peptides: An overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2007, 2, 1-33. (Pubitemid 46450753)
13. Diaz, G.A. Defensins and cystein rich peptides: Two types of antimicrobial peptide in marine molluscs. Invert. Surviv. J. 2010, 7, 157-164.
14. Rosa, R.D.; Barracco, M.A. Antimicrobial peptides in crustaceans. Invert. Surviv. J. 2010, 7, 262-284.
15. Matsunaga, S.; Fusetani, N.; Konosu, S. Bioactive marine metabolites, IV. Isolation and the amino acid composition of discodermin A, an antimicrobial peptide, from the marine sponge Discodermia kiiensis. J. Nat. Prod. 1985, 48, 236-241. (Pubitemid 15014786)
16. Otero-González, A.J.; Magalhães, B.S.; Garcia-Villarino, M.; López-Abarratequi, C.; Sousa, D.A.; Dias, S.C.; Franco, O.L. Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control. FASEB J. 2010, 24, 1320-1334.
17. Noga, E.J.; Ullal, A.J.; Corrales, J.; Fernandes, J.M. Application of antimicrobial polypeptide host defenses to aquaculture: Exploitation of downregulation and upregulation responses. Comp. Biochem. Physiol. Part D 2011, 6, 44-54.
18. Rakers, S.; Niklasson, L.; Steinhagen, D.; Kruse, C.; Schauber, J.; Sundell, K.; Paus, R. Antimicrobial peptides (AMPs) from fish epidermis: Perspective for investigative dermatology. J. Invest. Dermatol. 2013, 133, 1140-1149.
19. Patrzykat, A.; Gallant, J.W.; Seo, J.K.; Pytyck, J.; Douglas, S.E. Novel antimicrobial peptides derived from flatfish genes. Antimicrob. Agents Chemother. 2003, 47, 2464-2470. (Pubitemid 36919446)
20. Kim, J.Y.; Park, S.C.; Yoon, M.Y.; Hahm, K.S.; Park, Y. C-Terminal amidation of PMAP-23: Translocation to the inner membrane of Gram-negative bacteria. Amino Acids 2011, 40, 183-195.
21. Gopal, R.; Park, J.S.; Seo, C.H.; Park, Y. Applications of circular dichroism for structural analysis of gelatin and antimicrobial peptides. Int. J. Mol. Sci. 2012, 13, 3229-3244.
22. Findlay, B.; Zhanel, G.G.; Schweizer, F. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob. Agents Chemother. 2010, 54, 4049-4058.
23. Cole, A.M.; Darouiche, R.O.; Legarda, D.; Connell, N.; Diamond, G. Characterisation of a fish and antimicrobial peptide: Gene expression, subcellular localization, and spectrum of activity. Antimicrob. Agents Chemother. 2000, 44, 2039-2045. (Pubitemid 30484424)
24. Cho, J.; Choi, H.; Lee, D.G. Influence of the N- and C-terminal regions of antimicrobial peptide plurocidin on antibacterial activity. J. Microbiol. Biotechnol. 2012, 22, 1367-1374.
25. Kolmer, H.L.; Taketomi, E.A.; Hazen, K.C.; Hughs, E.; Wilson, B.B.; Platts-Mills, T.A. Effect of combined and antifungal treatment in severe atopic dermatitis. J. Allergy Clin. Immunol. 1996, 98, 702-707. (Pubitemid 26377938)
26. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A6; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2003.
27. Jeong, N.; Kim, J.Y.; Park, S.C.; Lee, J.K.; Gopal, R.; Yoo, S.; Son, B.K.; Hahm, J.S.; Park, Y.; Hahm, K.S. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microoganisms isolated from patients with cholelithiasis. Biochem. Biophys. Res. Commun. 2010, 399, 581-586.
28. Maisetta, G.; di Luca, M.; Esin, S.; Florio, W.; Brancatisano, F.L.; Bottai, D.; Campa, M.; Batoni, G. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 2008, 29, 1-6. (Pubitemid 350266113)
29. Goldman, M.J.; Anderson, G.M.; Stolzenberg, E.D.; Kari, U.P.; Zasloff, M.; Wilson, J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997, 88, 553-560. (Pubitemid 27154420)
30. Lee, I.H.; Cho, Y.; Lehrer, R.I. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect. Immun. 1997, 65, 2898-2903. (Pubitemid 27264123)
31. Bowdish, D.M.; Davidson, D.J.; Lau, Y.E.; Lee, K.; Scott, M.G.; Hancock, R.E. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005, 77, 451-459. (Pubitemid 40489520)
32. Tam, J.P.; Lu, Y.A.; Yang, J.L. Correlations of cationic charges with salt sensitivity and microbial specificity of cystine-stabilized β-strand antimicrobial peptides. J. Biol. Chem. 2002, 277, 50450-50456.
33. Høiby, N.; Krogh Johansen, H.; Moser, C.; Song, Z.; Ciofu, O.; Kharazmi, A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 2001, 3, 23-35. (Pubitemid 32172037)
34. Pruitt, B.A., Jr.; McManus, A.T.; Kim, S.H.; Goodwin, C.W. Burn wound infections: Current status. World J. Surg. 1998, 22, 135-145. (Pubitemid 28065179)
35. Tredget, E.E.; Shankowsky, H.A.; Rennie, R.; Burrell, R.E.; Logsetty, S. Pseudomonas infections in the thermally injured patient. Burns 2004, 30, 3-26. (Pubitemid 38029120)
36. Steven, L.P.; Philip, G.B. Biofilms and their potential role in wound healing. Wounds 2004, 16, 234-240.
37. Jabalameli, F.; Mirsalehian, A.; Khoramian, B.; Aligholi, M.; Khoramrooz, S.S.; Asadollahi, P.; Taherikalani, M.; Emaneini, M. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients. Burns 2012, 38, 1192-1197.
38. Harrison-Balestra, C.; Cazzaniga, A.L.; Davis, S.C.; Mertz, P.M. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol. Surg. 2003, 29, 631-635. (Pubitemid 36702450)
39. Serralta, V.W.; Harrison-Balestra, C.; Cazzaniga, A.L.; Davis, S.C.; Mertz, P.M. Lifestyles of bacteria in wounds: Presence of biofilms? Wounds 2001, 13, 29-34.
40. Schaber, J.A.; Triffo, W.J.; Suh, S.J.; Oliver, J.W.; Hastert, M.C.; Griswold, J.A.; Auer, M.; Hamood, A.N.; Rumbaugh, K.P. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect. Immun. 2007, 75, 3715-3721. (Pubitemid 47206268)
41. Sauer, K.; Camper, K.; Ehrlich, G.D.; Costerton, J.W.; Davies, D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 2002, 184, 1140-1154. (Pubitemid 34113383)
42. Whiteley, M.; Bangera, M.G.; Bumgarner, R.E.; Parsek, M.R.; Teitzel, G.M.; Lory, S.; Greenberg, E.P. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001, 413, 860-864. (Pubitemid 33026855)
43. Vidaillac, C.; Benichou, L.; Duval, R.E. In vitro synergy of colistin combinations against colistin resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 2012, 56, 4856-4861.
44. Donlan, R.M.; Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15, 167-193. (Pubitemid 34303762)
45. Sandoe, J.A.; Wysome, J.; West, A.P.; Heritage, J.; Wilcox, M.H. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against Enterococcal biofilms. J. Antimicrob. Chemother. 2006, 57, 767-770.
46. Evans, R.C.; Holmes, C.J. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicro. Agents Chemother. 1987, 31, 889-894. (Pubitemid 17084045)
47. Overhage, J.; Campisano, A.; Bains, M.; Torfs, E.C.; Rehm, B.H.; Hancock, R.E. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 2008, 76, 4176-4182.
48. Wei, G.X.; Campagna, A.N.; Bobek, L.A. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Chemother. 2006, 57, 1100-1109. (Pubitemid 44644411)
49. Eckert, R.; Brady, K.M.; Greenberg, E.P.; Qi, F.; Yarbrough, D.K.; He, J.; McHardy, I.; Anderson, M.H.; Shi, W. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob. Agents Chemother. 2006, 50, 3833-3838. (Pubitemid 44684900)
50. Pamp, S.J.; Gjermansen, M.; Johansen, H.K.; Tolker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 2008, 68, 223-240. (Pubitemid 351363790)
51. Nagant, C.; Pitts, B.; Nazmi, K.; Vandenbranden, M.; Bolscher, J.G.; Stewart, P.S.; Dehaye, J.P. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob. Agents Chemother. 2012, 56, 5698-5708.
52. Choi, H.; Lee, D.G. Antimicrobial peptide pleurocidin synergizes with antibiotics through hydroxyl radical formation and membrane damage, and exerts antibiofilm activity. Biochim. Biophys. Acta 2012, 1820, 1831-1838.
53. Dartois, V.; Sanchez-Quesada, J.; Cabezas, E.; Chi, E.; Dubbelde, C.; Dunn, C.; Granja, J.; Gritzen, C.; Weinberger, D.; Ghadiri, M.R.; et al. Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob. Agents Chemother. 2005, 49, 3302-3310.
54. Bowler, P.G.; Welsby, S.; Towers, V.; Booth, R.; Hogarth, A.; Rowlands, V.; Joseph, A.; Jones, S.A. Multidrug reistant organisms, wounds and topical application. Int. Wound J. 2012, 9, 387-396.
55. Nidadavolu, P.; Amor, W.; Tran, P.L.; Dertien, J.; Colmer-Hamood, J.A.; Hamood, A.N. Garlic ointment inhibits biofilm formation by bacterial pathogens from burn wounds. J. Med. Microbiol. 2012, 61, 662-671.
56. Ngo, Q.D.; Vickery, K.; Deva, A.K. The effect of topical negative pressure on wound biofilms using an in vitro wound model. Wound Repair Regen. 2012, 20, 83-90.
57. Ryu, S.; Choi, S.Y.; Acharya, S.; Chun, Y.J.; Gurley, C.; Park, Y.; Armstrong, C.A.; Song, P.I.; Kim, B.J. Antimicrobial and anti-inflammatory effects of cecropin A (1-8)-magainin 2(1-12) hybrid peptide analog P5 against Malassezia furfur infection in human ketatinocytes. J. Invest. Dermatol. 2011, 131, 1677-1683.
58. Javadpour, M.M.; Juban, M.M.; Lo, W.C.; Bishop, S.M.; Alberty, J.B.; Cowell, S.M.; Becker, C.L.; Mclaughlin, M.L. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 1996, 39, 3107-3113.
59. Fernandez-Lopez, S.; Kim, H.S.; Choi, E.C.; Delgado, M.; Granja, J.R.; Khasanov, A.; Kraehenbuehl, K.; Long, G.; Weinberger, D.A.; Wilcoxen, K.M.; et al. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature 2001, 412, 452-455.
60. Chan, D.I.; Prenner, E.J.; Vogel, H.J. Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochim. Biophys. Acta 2006, 1758, 1184-1202.
61. Schibli, D.J.; Hwang, P.M.; Vogel, H.J. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 1999, 446, 213-217. (Pubitemid 29132728)
62. Jing, W.; Hunter, H.N.; Hagel, J.; Vogel, H.J. The structure of the antimicrobial peptide Ac-RRWWRF-NH2 bound to micelles and its interactions with phospholipid bilayers. J. Pept. Res. 2003, 61, 219-229. (Pubitemid 36570796)
63. Glukhov, E.; Stark, M.; Burrows, L.L.; Deber, C.M. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 2005, 280, 33960-33967. (Pubitemid 41443116)
64. Andra, J.; Monreal, D.; Martinez de Tejada, G.; Olak, C.; Brezesinski, G.; Gomez, S.S.; Goldmann, T.; Bartels, R.; Brandenburg, K.; Moriyon, I. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J. Biol. Chem. 2007, 282, 14719-14728. (Pubitemid 47093359)
65. Hawrani, A.; Howe, R.A.; Walsh, T.R.; Dempsey, C.E. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides. J. Biol. Chem. 2008, 283, 18636-18645.
66. Gopal, R.; Park, S.C.; Ha, K.J.; Cho, S.J.; Kim, S.W.; Song, P.I.; Nah, J.W.; Park, Y.; Hahm, K.S. Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide. J. Pept. Sci. 2009, 15, 589-594.
67. Pandey, B.K.; Ahmad, A.; Asthana, N.; Azmi, S.; Srivastava, R.M.; Srivastava, S.; Verma, R.; Vishwakarma, A.L.; Ghosh, J.K. Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli. Biochemistry 2010, 49, 7920-7929.
68. Gopal, R.; Seo, C.H.; Song, P.I.; Park, Y. Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino Acids 2013, 44, 645-660.
69. Gill, S.C.; von Hippel, P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 1989, 182, 319-326.
70. Park, S.C.; Kim, J.Y.; Lee, J.K.; Hwang, I.; Cheong, H.; Nah, J.W.; Hahm, K.S.; Park, Y. Antifungal mechanism of a novel antifungal protein from pumpkin rinds against various fungal pathogens. J. Agric. Food. Chem. 2009, 57, 9299-9304.
71. Rolli, E.; Ragni, E.; de Medina-Redondo, M.; Arroyo, J.; de Aldana, C.R.; Popolo, L. Expression, stability, and replacement of glucan-remodeling enzymes during developmental transition in Saccharomyces cerevisiae. Mol. Biol. Cell. 2011, 22, 1585-1598.
72. Gopal, R.; Na, H.; Seo, C.H.; Park, Y. Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum. Int. J. Mol. Sci. 2012, 13, 15042-15053.
73. Christensen, G.D.; Simpson, W.A.; Younger, J.J.; Baddour, F.F.; Barrett, D.M.; Melton, D.M.; Beachey, E.H. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 1985, 22, 996-1006.
74. Mayer, L.D.; Hope, M.J.; Cullis, P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochem. Biophys. Acta 1986, 858, 161-168.
75. Stewart, J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980, 104, 10-14. (Pubitemid 10045896)
76. Gopal, R.; Lee, J.K.; Lee, J.H.; Kim, Y.G.; Oh, G.C.; Seo, C.H.; Park, Y. Effect of repetitive lysine-tryptophan motifs on the eukaryotic membrane. Int. J. Mol. Sci. 2013, 14, 2190-2202.
77. Chongsiriwatana, N.P.; Barron, A.E. Comparing bacterial membrane interactions of antimicrobial peptides and their mimics. Methods Mol. Biol. 2010, 618, 171-182.
78. Allen, T.M.; Cleland, L.G. Serum-induced leakage of liposome contents. Biochim. Biophys. Acta 1980, 10, 418-426. (Pubitemid 10066496)